Virtus LifeSci Biotech Products ETF BBP

Medalist Rating as of | See Virtus Investment Hub

Morningstar’s Analysis BBP

Will BBP outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Virtus LifeSci Biotech Products ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBP

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 27.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Moderna Inc

5.01 6M
Healthcare

Iovance Biotherapeutics Inc

4.58 6M
Healthcare

Omeros Corp

2.80 4M
Healthcare

Precigen Inc

2.52 3M
Healthcare

Verastem Inc

2.47 3M
Healthcare

Halozyme Therapeutics Inc

2.08 3M
Healthcare

Kiniksa Pharmaceuticals International PLC Class A

1.92 2M
Healthcare

ImmunityBio Inc Ordinary Shares

1.91 2M
Healthcare

Rigel Pharmaceuticals Inc

1.89 2M
Healthcare

Zai Lab Ltd ADR Repr 1 Shs

1.87 2M
Healthcare

Sponsor Center